First In Human Study of CX-2051 in Advanced Solid Tumors

Clinical trial NCT06265688 · RECRUITING

Trial details

NCT number: NCT06265688
Sponsor: CytomX Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor, Adult

Start date: 2024-04-02
Primary completion: 2027-11-30
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.